SNapShot®-analysis showed FGFR3 mutations in 6 of 71 samples (8.5%, all p.S249C, n = 3 pure squamous carcinomas and n = 3 mixed carcinomas) (Figure 2A, Supplementary Data S1). This evidence concerns the gene FGFR3 and squamous cell carcinoma.